Product image of Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Sodium Chloride, Calcium Chloride Dihydra) supplied by GNH India

Multibic

Active Ingredient:
Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Sodium Chloride, Calcium Chloride Dihydra
Origin:
EU

Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Sodium Chloride, Calcium Chloride Dihydra)

Sodium Hydrogen Carbonate, the active ingredient in Multibic, is an electrolyte solution presented as a solution for injection for haemodialysis and intravenous use. It corrects electrolyte imbalances and supports acid‑base balance in patients undergoing dialysis.
GNH India supplies Multibic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and dialysis clinics worldwide.

Manufacturer / TM Owner

Fresenius Medical Care Deutschland Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Multibic is used to manage electrolyte and acid‑base disturbances during haemodialysis and intravenous therapy.

  • Haemodialysis: provides sodium, chloride, calcium, magnesium and bicarbonate to maintain electrolyte homeostasis.
  • Intravenous therapy in critically ill patients: supports acid‑base balance when rapid correction is needed.
  • Renal replacement therapy: assists in preventing electrolyte depletion during continuous renal replacement therapy (CRRT).

How It Works

  • Multibic delivers sodium, chloride, calcium, magnesium and bicarbonate ions directly into the bloodstream. The supplied ions replenish deficits caused by dialysis or acute illness, while bicarbonate buffers excess hydrogen ions to correct metabolic acidosis. By restoring extracellular electrolyte concentrations, the solution helps maintain membrane potential, cardiac contractility and neuromuscular function.

Side Effects

Multibic may cause a range of adverse reactions, most of which are related to electrolyte shifts or the injection process.

Common Side Effects

  • Injection site pain: mild discomfort at the infusion site.
  • Transient hypernatremia: temporary elevation of serum sodium.
  • Mild hypotension: slight drop in blood pressure during rapid infusion.
  • Mild metabolic alkalosis: modest increase in blood pH.

Serious or Rare Side Effects

  • Severe hyperkalemia: dangerous rise in potassium levels.
  • Severe hypermagnesemia: excessive magnesium causing cardiac effects.
  • Anaphylactic reaction: acute allergic response requiring emergency care.
  • Severe fluid overload: pulmonary edema or heart failure from excess volume.

Precautions & Warnings

When using Multibic, clinicians should observe several safety measures.

  • Renal function: monitor serum electrolytes closely during therapy.
  • Cardiac status: watch for arrhythmias related to rapid electrolyte changes.
  • Fluid balance: avoid excessive volume administration, especially in heart‑failure patients.
  • Pregnancy and lactation: use only if the anticipated benefit justifies potential risk.
  • Concomitant electrolyte supplements: adjust doses to prevent overload.
  • Store at controlled room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Multibic can interact with other medications that affect electrolyte or fluid status.

Major Interactions (Avoid)

  • Calcium channel blockers: may potentiate hypercalcemia.
  • Loop diuretics: increase risk of electrolyte imbalance.
  • Alkali therapy: may cause excessive alkalosis.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: monitor potassium levels.
  • Beta‑blockers: watch for blood pressure changes.
  • Other intravenous electrolytes: adjust dosing to avoid cumulative overload.

Frequently Asked Questions

Multibic is an injectable electrolyte solution used primarily during haemodialysis and other forms of renal replacement therapy. It supplies sodium, chloride, calcium, magnesium and bicarbonate to correct electrolyte deficits and to help maintain acid‑base balance in patients who require rapid intravenous correction.

The formulation provides essential ions that are lost during dialysis or acute illness. Sodium and chloride restore extracellular fluid volume, calcium and magnesium support cardiac and neuromuscular function, and bicarbonate acts as a buffer to neutralise excess hydrogen ions, thereby correcting metabolic acidosis.

The dose of Multibic is individualized by the prescribing clinician based on the patient’s electrolyte profile, fluid status and the specific dialysis protocol. No fixed regimen is provided; the prescriber determines the volume and rate of infusion required for each case.

Safety data for Multibic in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and the necessary import documentation.

Compared with standard saline or lactated Ringer’s solutions, Multibic contains a broader spectrum of electrolytes, including calcium, magnesium and bicarbonate, making it more suitable for patients undergoing dialysis who need comprehensive electrolyte repletion and acid‑base correction.

Multibic should be stored at controlled room temperature, below 25 °C, in its original packaging. Protect the solution from direct sunlight, moisture and extreme temperature fluctuations. Inspect the container for any signs of damage before use.

Multibic is administered intravenously, either as a direct infusion during haemodialysis or as a separate IV infusion in critically ill patients. The infusion rate and total volume are determined by the treating clinician according to the patient’s clinical needs.

The most serious risks include severe hyperkalemia, severe hypermagnesemia, anaphylactic reactions and fluid overload leading to pulmonary edema or heart failure. Continuous monitoring of serum electrolytes and fluid status is essential during therapy.

Multibic is contraindicated in patients with known hypersensitivity to any of its components, in those with uncontrolled severe hypercalcemia or hypermagnesemia, and in individuals where rapid fluid administration could exacerbate heart failure or pulmonary edema.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.